AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Monetary Success of Zempic and Wigovie, Bans on Ozempic, and Advice for Health Industry Professionals
Discussion on the significant financial success of Zempic and Wigovie, which generated $4.8 billion in sales and accounted for 52% of Nordisk's revenue. Mention of Ozempic's off-label use for weight loss and its bans in several countries, followed by advice for aspiring health industry professionals.